Your browser doesn't support javascript.
loading
CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration.
Nguyen, Khanh T P; Druhan, Lawrence J; Avalos, Belinda R; Zhai, Li; Rauova, Lubica; Nesmelova, Irina V; Dréau, Didier.
Afiliación
  • Nguyen KTP; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, United States of America.
  • Druhan LJ; Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States of America; Center for Biomedical Engineering and Science, UNC Charlotte, Charlotte, NC, United States of America.
  • Avalos BR; Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States of America; Center for Biomedical Engineering and Science, UNC Charlotte, Charlotte, NC, United States of America.
  • Zhai L; Department of Pediatrics, The Children's Hospital of Philadelphia, PA, United States of America.
  • Rauova L; Department of Pediatrics, The Children's Hospital of Philadelphia, PA, United States of America; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
  • Nesmelova IV; Center for Biomedical Engineering and Science, UNC Charlotte, Charlotte, NC, United States of America; Department of Physics and Optical Science, UNC Charlotte, Charlotte, NC, United States of America.
  • Dréau D; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, United States of America; Center for Biomedical Engineering and Science, UNC Charlotte, Charlotte, NC, United States of America. Electronic address: ddreau@uncc.edu.
Cell Signal ; 66: 109488, 2020 02.
Article en En | MEDLINE | ID: mdl-31785332
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor Plaquetario 4 / Adenocarcinoma / Quimiocina CXCL12 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Cell Signal Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor Plaquetario 4 / Adenocarcinoma / Quimiocina CXCL12 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Cell Signal Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos